Annual SG&A
$9.03 M
-$3.58 M-28.37%
31 December 2022
Summary:
Scopus BioPharma annual selling, general & administrative expenses is currently $9.03 million, with the most recent change of -$3.58 million (-28.37%) on 31 December 2022. During the last 3 years, it has risen by +$6.30 million (+230.63%). SCPS annual SG&A is now -28.37% below its all-time high of $12.61 million, reached on 31 December 2021.SCPS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$935.90 K
-$134.80 K-12.59%
30 June 2023
Summary:
Scopus BioPharma quarterly selling, general & administrative expenses is currently $935.90 thousand, with the most recent change of -$134.80 thousand (-12.59%) on 30 June 2023. SCPS quarterly SG&A is now -85.34% below its all-time high of $6.38 million, reached on 31 December 2021.SCPS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$218.05 M
-$8.70 M-4.15%
30 June 2023
Summary:
Scopus BioPharma TTM selling, general & administrative expenses is currently -$218.05 million, with the most recent change of -$8.70 million (-4.15%) on 30 June 2023. SCPS TTM SG&A is now -15029.42% below its all-time high of $16.03 million, reached on 30 June 2022.SCPS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +230.6% | -65.1% | -3272.6% |
| 5 y5 years | +2111.8% | +30.9% | -10000.0% |
SCPS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.4% | +230.6% | -85.3% | at low | -116.1% | at low |
| 5 y | 5 years | -28.4% | +2111.8% | -85.3% | +64.5% | -3033.3% | at low |
| alltime | all time | -28.4% | +2111.8% | -85.3% | +939.9% | <-9999.0% | at low |
Scopus BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $935.90 K(-12.6%) | $4.08 M(-29.8%) |
| Mar 2023 | - | $1.07 M(-1.8%) | $5.81 M(-35.7%) |
| Dec 2022 | $9.03 M(-28.4%) | $1.09 M(+11.1%) | $9.03 M(-36.9%) |
| Sept 2022 | - | $981.30 K(-63.2%) | $14.33 M(-10.6%) |
| June 2022 | - | $2.67 M(-37.8%) | $16.03 M(+6.3%) |
| Mar 2022 | - | $4.29 M(-32.8%) | $15.08 M(+19.6%) |
| Dec 2021 | $12.61 M(+361.6%) | $6.38 M(+138.0%) | $12.61 M(+83.5%) |
| Sept 2021 | - | $2.68 M(+55.3%) | $6.87 M(+37.6%) |
| June 2021 | - | $1.73 M(-5.0%) | $5.00 M(+25.5%) |
| Mar 2021 | - | $1.82 M(+182.2%) | $3.98 M(+45.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $2.73 M(+22.7%) | $644.60 K(-20.0%) | $2.73 M(-4.7%) |
| Sept 2020 | - | $806.00 K(+13.4%) | $2.87 M(+3.3%) |
| June 2020 | - | $710.70 K(+24.9%) | $2.78 M(+15.5%) |
| Mar 2020 | - | $569.00 K(-27.1%) | $2.40 M(+7.9%) |
| Dec 2019 | $2.23 M(+445.2%) | $780.30 K(+9.1%) | $2.23 M(+53.9%) |
| Sept 2019 | - | $715.10 K(+111.3%) | $1.45 M(+97.8%) |
| June 2019 | - | $338.40 K(-13.9%) | $731.40 K(+42.7%) |
| Mar 2019 | - | $393.00 K(+228.3%) | $512.70 K(+144.5%) |
| Dec 2018 | $408.40 K | - | - |
| June 2018 | - | $119.70 K(+33.0%) | $209.70 K(+133.0%) |
| Mar 2018 | - | $90.00 K | $90.00 K |
FAQ
- What is Scopus BioPharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Scopus BioPharma?
- What is Scopus BioPharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Scopus BioPharma?
- What is Scopus BioPharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Scopus BioPharma?
What is Scopus BioPharma annual selling, general & administrative expenses?
The current annual SG&A of SCPS is $9.03 M
What is the all time high annual SG&A for Scopus BioPharma?
Scopus BioPharma all-time high annual selling, general & administrative expenses is $12.61 M
What is Scopus BioPharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of SCPS is $935.90 K
What is the all time high quarterly SG&A for Scopus BioPharma?
Scopus BioPharma all-time high quarterly selling, general & administrative expenses is $6.38 M
What is Scopus BioPharma TTM selling, general & administrative expenses?
The current TTM SG&A of SCPS is -$218.05 M
What is the all time high TTM SG&A for Scopus BioPharma?
Scopus BioPharma all-time high TTM selling, general & administrative expenses is $16.03 M